Strait of Hormuz disruption impacts India's pharma sector
pre-market1 source ↓written by the desknot a recommendation
- 9.4% YoY growth
- target regulated markets
- 60% of exports
The Strait of Hormuz disruption highlights India's pharmaceutical sector's reliance on secure energy access. With exports reaching US$30.47 billion in FY2024-25, a 9.4% YoY growth, the sector's stability is crucial. Over 60% of exports target regulated markets, emphasizing the need for reliable logistics and petrochemical supplies. 📦⚗️
Not investment advice. For informational purposes only.